Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
5 results
  • Sarcoma, Liver Cancer, Metastatic/Advanced Cancer, Gallbladder and Bile Duct Cancers, Brain Tumors

20-487          Phase I

A Phase 1 Study of LY3410738 Administered to Patients with Advanced Solid Tumors with IDH1 Mutations (View details on clinicaltrial.gov)

  • Gallbladder and Bile Duct Cancers

19-502          Phase III

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib Versus Gemcitabine With Cisplatin in Subjects With Advanced/Metastatic or Inoperable Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations: the PROOF Trial (View details on clinicaltrial.gov)

  • Liver Metastases, Gallbladder and Bile Duct Cancers

17-517          Phase II

A Phase II Trial of Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer (View details on clinicaltrial.gov)

  • Gallbladder and Bile Duct Cancers, Liver Cancer

20-645          Phase III

An Open-Label Expanded Access Program of Futibatinib (TAS-120) In Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements (View details on clinicaltrial.gov)

  • Gallbladder and Bile Duct Cancers, Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Ovarian Cancer

21-121          Phase II

First in Human Phase 1/2 Trial of ELI-002 Immunotherapy as Treatment for Subjects with Kirsten Rat Sarcoma (KRAS) Mutated Pancreatic Ductal Adenocarcinoma and Other Solid Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 5 results